MedTrace Logo

Initial Intervention Efficacy for an Online PTSD Intervention for Pregnant Women

NCT04264520 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2024-10-24

No results posted yet for this study

Summary

The current study aims to test a brief computer-assisted intervention (psychoeducation + skills) for pregnant women with elevated PTSD symptoms. In this open trial pilot feasibility study, 20 pregnant women in their first trimester will be invited to participate in the study if they endorse elevated PTSD symptoms. Oxytocin and cortisol will be measured at baseline, one month post-intervention, three months post-intervention, and post-delivery to inform the relationship between these hormones, PTSD symptoms, and peripartum/postpartum outcomes. In addition to receiving the psychoeducation + skills intervention during their first trimester, women will be offered a "booster session" intervention following delivery to enhance utilization of skills during a critical period for maternal mental and physical health outcomes.

Conditions

  • Perinatal Problems
  • Post Traumatic Stress Disorder
  • Post Partum Depression

Interventions

BEHAVIORAL

PTSD Psychoeducation + Skills Intervention

A brief computer-assisted intervention (psychoeducation + skills) for pregnant women with elevated PTSD symptoms.

Sponsors & Collaborators

  • MUSC Specialized Center of Research Excellence

    collaborator UNKNOWN

  • Medical University of South Carolina

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-05
Primary Completion
2021-04-23
Completion
2021-04-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04264520 on ClinicalTrials.gov